Masimo proxy fight nears end as shareholder vote looms.

CHIEF operating officers; PULSE oximetry; OXYGEN saturation; BOARDS of directors; PRELIMINARY injunctions; OXIMETRY

The battle for control of medical device company Masimo is reaching its climax as shareholders prepare to vote on whether to support Chairman and CEO Joe Kiani or elect activist investor Politan Capital Management's candidates to the board. The two-year-long dispute has seen both sides publicly attack each other, with a federal judge recently finding Politan and its managing partner in contempt of court for disclosing sealed information. Proxy advisory firms have taken sides, with ISS and Glass Lewis recommending shareholders vote for Politan's nominees, while Egan-Jones Proxy Services supports Kiani and his team. [Extracted from the article]

Copyright of MedTech Dive is the property of Industry Dive and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)